Understanding disease at cellular and molecular level – University of Copenhagen

Forward this page to a friend Resize Print Bookmark and Share

Research > Strengths > Interdisciplinary strengths > Health & lifestyle > Cells & molecules

Research into understanding disease at cellular and molecular level

Basic knowledge about cells, their differences and how they communicate with each other, is necessary for understanding what happens when we become sick. In recent years, our understanding of diseases and how they occur at cellular and molecular level has grown exponentially. In particular, the latest advances in genome sequencing have advanced knowledge of genetic components making it possible to pose, and answer, brand new questions. Better understanding of communication networks within and between cells also paves the way for new paths towards the treatment and prevention of diseases. Researchers at the University of Copenhagen are working to decode and understand the mechanisms behind diseases such as diabetes, cancer and malaria. Below are some examples of the new knowledge that researchers have already identified. 

light microscopy of a paraffin embedded mouse islet; labels: insulin green, glucagon red, nuclei blueDevelopment of insulin-producing beta cells

Insulin is a hormone produced in the pancreas, by what are called beta cells. In people with type 1 diabetes, the beta cells are destroyed by the patient's own immune system. The aim is therefore to develop insulin-producing beta cells. This will require an understanding of the mechanisms that control the formation of beta cells. Researchers from DanStem have shown that the so-called 'notch' signal's ability to inhibit and then stimulate the formation of hormone-producing cells is important for monitoring the development of the beta cells.

Stamceller

Several cancers may be caused by diseased stem cells

The discovery of more and more of the cells that maintain tissue and organs throughout life (the stem cells) offers new perspectives for the treatment of diseases. In order to find new principles for treatment, we must be able to compare cancer cells with their normal cell of origin. This will only be possible with a sufficient understanding of the organ's normal cellular hierarchy. Significant and highly promising new 'drug targets' deal with the micro-environment's importance for tumour growth and metastasis, in particular the signalling pathways and glycosylation.

Blodposer hænger på et stativ

Changing all types of blood to 0

The difference between blood groups A, B and 0 is a particular carbohydrate, contained in red blood cells. Prior to a blood transfusion or organ transplant, it is important to ascertain that donor and recipient share the same blood group. Otherwise people may die. Group 0 lacks a sugar, A has one type of sugar, B another and ABs have both kinds. If a particular sugar is missing, antibodies are present. Researchers at the Copenhagen Center for Glycomics have identified the genes that determine people's blood group, and have developed enzymes that remove these sugars. It is therefore now possible to transform all types of blood into group 0, and use it in transfusions for everybody.

Dopamine, reward and cocaine

Dopamine is one of the brain's most important neurotransmitters and controls our motivation to obtain a reward. The amount of dopamine in the brain's synapses is controlled by a particular protein, the dopamine transporter, which conveys dopamine back into the nerve cell. Drugs like cocaine and amphetamines work by blocking the dopamine transporter. Detailed insight into how cocaine blocks the dopamine transporter at the molecular level has provided new ideas about how it might be possible to treat cocaine abuse. New research has also shown that a particular family of 'scaffold proteins' (PDZ domain proteins) plays a surprisingly important role in the presence of the dopamine transporter in the synapse. This insight can be used, for example, to better understand diseases in which changes in the dopamine balance play an important role, e.g. schizophrenia, ADHD and Parkinson's disease.

Både A- og D-vitaminer er vigtige for et velfungerende immunsystem. Billedet viser et glas vitaminpiller.Vitamins for the immune system

Both vitamin A and D are important to a properly functioning immune system. New research shows how these vitamins affect the immune system.

 

Kvinde kigger på termometer og holder sig selv på panden.One vaccine against the influenza virus

Approximately every two years, an influenza epidemic breaks out, mortality rates increase, especially in the elderly population, and it costs society money in lost working days. It is possible to vaccinate against influenza, but the vaccines need to be adapted almost every year because the virus changes. Certain properties of the influenza virus are, however, very stable and, by targeting a vaccine on these antigens, it will probably be possible to develop a vaccine that will work for many years.

Blodprøve i forbindelse med hepatitisNew culture systems for the production of the hepatitis C virus

Approximately 170 million people have hepatitis C, and at least 350,000 die of complications every year. It is crucial for the development of medicines that attack the virus directly, as well as for the development of vaccines, to be able to cultivate hepatitis C variants in cells in the laboratory.

Bakteriel biofilm på et kunstigt knæ, der er fjernet igen.Chronic infections and biofilms

The formation of bacterial biofilms is a frequent cause of chronic infections and is extremely difficult to treat with ordinary antibiotics. Biofilms are responsible for infections in artificial heart valves, knee and hip replacements and medical devices such as catheters, etc. New types of 'antibiotics' – such as ajoene from garlic – have been found to inhibit bacterial communication systems (quorum sensing) so that the host's defence systems can eliminate the bacterial biofilm.

Malriamyg (Anopehles Gambiae). Foto: James Gathamy. Identification of parasite proteins that cause life-threatening malaria

Every year, approximately one million children die from malaria and about 20 million suffer severe bouts of the disease. Several hundred million cases of malaria are recorded every year, so far from every case is life-threatening. Researchers have now identified the proteins that are responsible for some cases of malaria becoming serious.